Overview of cotinine cutoff values for smoking status classification

International Journal of Environmental Research and Public Health

Volumn 13, Issue 12, 2016, Pages

  Kim, Sungroul ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

Biomarker; Cotinine; Cutoff value; Smoking status

Indexed keywords

COTININE; BIOLOGICAL MARKER;

BIOMARKER; CLASSIFICATION; SERUM; SMOKING;

BLOOD LEVEL; CLASSIFICATION; HUMAN; POPULATION RESEARCH; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; REVIEW; SALIVA LEVEL; SELF REPORT; SENSITIVITY AND SPECIFICITY; SMOKING; UNITED KINGDOM; UNITED STATES; URINE LEVEL; VALIDATION STUDY; ADULT; BLOOD; CHEMISTRY; FEMALE; METABOLISM; SALIVA; URINE;

UNITED KINGDOM; UNITED STATES;

ADULT; BIOMARKERS; COTININE; FEMALE; HUMANS; ROC CURVE; SALIVA; SENSITIVITY AND SPECIFICITY; SMOKING;

EID: 85007232630     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph13121236     Document Type: Review

References (62)

1. International Agency for Research on Cancer IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans: Tobacco Smoke and Involuntary Smoking; International Agency for Research on Cancer: Lyon, France, 1986; Volume 38.
2. National Research Council. Environmental Tobacco Smoke: Measuring Exposures and Assessing Health Effects; National Academy Press: Washington, DC, USA, 1986.
3. U.S. Department of Health and Human Services. The Health Consequences of Involuntary Smoking. A Report of the Surgeon General; (CDC) 87-8398; U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Health Promotion and Education, Office on Smoking and Health: Rockville, MD, USA, 1986.
4. Warren, C.W.; Jones, N.R.; Eriksen, M.P.; Asma, S. Patterns of global tobacco use in young people and implications for future chronic disease burden in adults. Lancet 2006, 367, 749–753. [CrossRef]
5. Kawachi, I.; Colditz, G.A. Invited commentary: Confounding, measurement error, and publication bias in studies of passive smoking. Am. J. Epidemiol. 1996, 144, 909–915. [CrossRef] [PubMed]
6. Wells, A.J.; English, P.B.; Posner, S.F.; Wagenknecht, L.E.; Perez-Stable, E.J. Misclassification rates for current smokers misclassified as nonsmokers. Am. J. Public Health 1998, 88, 1503–1509. [CrossRef] [PubMed]
7. Benowitz, N.L. The use of biologic fluid samples in assessing tobacco smoke consumption. In Measurement in the Analysis and Treatment of Smoking Behavior; NIDA Research Monograph, No. 48; National Institute on Drug Abuse: Rockville, MD, USA, 1983.
8. Benowitz, N.L. Biomarkers of environmental tobacco smoke exposure. Environ. Health Perspect. 1999, 107 (Suppl S2), 349–355. [CrossRef] [PubMed]
9. Coultas, D.B.; Howard, C.A.; Peake, G.T.; Skipper, B.J.; Samet, J.M. Salivary cotinine levels and involuntary tobacco smoke exposure in children and adults in New Mexico. Am. Rev. Respir. Dis. 1987, 136, 305–309. [CrossRef] [PubMed]
10. DeLorenze, G.N.; Kharrazi, M.; Kaufman, F.L.; Eskenazi, B.; Bernert, J.T. Exposure to environmental tobacco smoke in pregnant women: The association between self-report and serum cotinine. Environ. Res. 2002, 90, 21–32. [CrossRef] [PubMed]
11. Eliopoulos, C.; Klein, J.; Koren, G. Validation of self-reported smoking by analysis of hair for nicotine and cotinine. Ther. Drug Monit. 1996, 18, 532–536. [CrossRef] [PubMed]
12. Etzel, R.A. A review of the use of saliva cotinine as a marker of tobacco smoke exposure. Prev. Med. 1990, 19, 190–197. [CrossRef]
13. National Research Council. Biologic Markers of Pulmonay Toxicology; National Academy Press: Washington, DC, USA, 1989.
14. Benowitz, N.L.; Jacob, P., III; Fong, I.; Gupta, S. Nicotine metabolic profile in man: Comparison of cigarette smoking and transdermal nicotine. J. Pharmacol. Exp. Ther. 1994, 268, 296–303. [PubMed]
15. Benowitz, N.L.; Jacob, P., III. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin. Pharmacol. Ther. 1994, 56, 483–493. [CrossRef] [PubMed]
16. Jacob, P.I.; Byrd, G.D. Use of gas chromatographic and mass spectrometric techniques for the determination of nicotine and its metabolites. In Analytical Determination of Nicotine and Related Compounds and Their Metabolites; Gorrod, J.W., Jacob, P.I., Eds.; Elsevier Science: Amsterdam, The Netherlands, 1999; pp. 191–224.
17. Benner, C.L.; Bayona, J.M.; Caka, F.M.; Tang, H.; Kewis, L.; Crawford, J.; Lamb, J.D.; Lee, M.L.; Lewis, E.A.; Hansen, L.D.; et al. Chemical composition of environmental tobacco smoke. 2. Particulate-phase compounds. Environ. Sci. Technol. 1986, 23, 688–699. [CrossRef]
18. Ogden, M.W.; Maiolo, K.C.; Nelson, P.R.; Heavner, D.L.; Green, C.R. Artifacts in determining the vapor-particulate phase distribution of environmental tobacco smoke nicotine. Environ. Technol. 1993, 14, 779–785. [CrossRef]
19. Benowitz, N.L. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol. Rev. 1996, 18, 188–204. [CrossRef] [PubMed]
20. Hammond, S.K.; Leaderer, B.P. A diffusion monitor to measure exposure to passsive smoking. Environ. Sci. Technol. 1987, 21, 494–497. [CrossRef] [PubMed]
21. Jaakkola, M.S.; Jaakkola, J.J. Assessment of exposure to environmental tobacco smoke. Eur. Respir. J. 1997, 10, 2384–2397. [CrossRef] [PubMed]
22. Flegal, K.M.; Brownie, C.; Haas, J.D. The effects of exposure misclassification on estimates of relative risk. Am. J. Epidemiol. 1986, 123, 736–751. [PubMed]
23. Boyd, N.R.; Windsor, R.A.; Perkins, L.L.; Lowe, J.B. Quality of measurement of smoking status by self-report and saliva cotinine among pregnant women. Matern. Child Health J. 1998, 2, 77–83. [CrossRef] [PubMed]
24. Etter, J.F.; Vu, D.T.; Perneger, T.V. Saliva cotinine levels in smokers and nonsmokers. Am. J. Epidemiol. 2000, 151, 251–258. [CrossRef] [PubMed]
25. Hegaard, H.K.; Kjaergaard, H.; Moller, L.F.; Wachmann, H.; Ottesen, B. Determination of a saliva cotinine cut-off to distinguish pregnant smokers from pregnant non-smokers. Acta Obstet. Gynecol. Scand. 2007, 86, 401–406. [CrossRef] [PubMed]
26. Jarvis, M.; Tunstall-Pedoe, H.; Feyerabend, C.; Vesey, C.; Salloojee, Y. Biochemical markers of smoke absorption and self reported exposure to passive smoking. J. Epidemiol. Community Health 1984, 38, 335–339. [CrossRef] [PubMed]
27. Jarvis, M.J.; Tunstall-Pedoe, H.; Feyerabend, C.; Vesey, C.; Saloojee, Y. Comparison of tests used to distinguish smokers from nonsmokers. Am. J. Public Health 1987, 77, 1435–1438. [CrossRef] [PubMed]
28. Luepker, R.V.; Pallonen, U.E.; Murray, D.M.; Pirie, P.L. Validity of telephone surveys in assessing cigarette smoking in young adults. Am. J. Public Health 1989, 79, 202–204. [CrossRef] [PubMed]
29. McNeill, A.D.; West, R.J.; Jarvis, M.; Jackson, P.; Bryant, A. Cigarette withdrawal symptoms in adolescent smokers. Psychopharmacology 1986, 90, 533–536. [CrossRef] [PubMed]
30. Murray, R.P.; Connett, J.E.; Lauger, G.G.; Voelker, H.T. Error in smoking measures: Effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking. The Lung Health Study Research Group. Am. J. Public Health 1993, 83, 1251–1257. [CrossRef] [PubMed]
31. Pierce, J.P.; Dwyer, T.; DiGiusto, E.; Carpenter, T.; Hannam, C.; Amin, A.; Yong, C.; Sarfaty, G.; Shaw, J.; Burke, N. Cotinine validation of self-reported smoking in commercially run community surveys. J. Chronic Dis. 1987, 40, 689–695. [CrossRef]
32. Stookey, G.K.; Katz, B.P.; Olson, B.L.; Drook, C.A.; Cohen, S.J. Evaluation of biochemical validation measures in determination of smoking status. J. Dent. Res. 1987, 66, 1597–1601. [CrossRef] [PubMed]
33. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 2002, 4, 149–159.
34. Hoffmann, D.; Haley, N.J.; Adams, J.D.; Brunnemann, K.D. Tobacco sidestream smoke: Uptake by nonsmokers. Prev. Med. 1984, 13, 608–617. [CrossRef]
35. Slattery, M.L.; Hunt, S.C.; French, T.K.; Ford, M.H.; Williams, R.R. Validity of cigarette smoking habits in three epidemiologic studies in Utah. Prev. Med. 1989, 18, 11–19. [CrossRef]
36. Martinez, M.E.; Reid, M.; Jiang, R.; Einspahr, J.; Alberts, D.S. Accuracy of self-reported smoking status among participants in a chemoprevention trial. Prev. Med. 2004, 38, 492–497. [CrossRef] [PubMed]
37. Benowitz, N.L.; Bernert, J.T.; Caraballo, R.S.; Holiday, D.B.; Wang, J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am. J. Epidemiol. 2009, 169, 236–248. [CrossRef] [PubMed]
38. Goniewicz, M.L.; Eisner, M.D.; Lazcano-Ponce, E.; Zielinska-Danch, W.; Koszowski, B.; Sobczak, A.; Havel, C.; Jacob, P.; Benowitz, N.L. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking. Nicotine Tob. Res. 2011, 13, 202–208. [CrossRef] [PubMed]
39. Jarvis, M.J.; Fidler, J.; Mindell, J.; Feyerabend, C.; West, R. Assessing smoking status in children, adolescents and adults: Cotinine cut-points revisited. Addiction 2008, 103, 1553–1561. [CrossRef] [PubMed]
40. Stragierowicz, J.; Mikołajewska, K.; Zawadzka-Stolarz, M.; Polańska, K.; Ligocka, D. Estimation of cutoff values of cotinine in urine and saliva for pregnant women in Poland. Biomed Res. Int. 2013, 2013, 386784. [CrossRef] [PubMed]
41. Smith, J.J.; Robinson, R.F.; Khan, B.A.; Sosnoff, C.S.; Dillard, D.A. Estimating cotinine associations and a saliva cotinine level to identify active cigarette smoking in Alaska native pregnant women. Matern. Child Health J. 2014, 18, 120–128. [CrossRef] [PubMed]
42. Williams, C.L.; Eng, A.; Botvin, G.J.; Hill, P.; Wynder, E.L. Validation of students’ self-reported cigarette smoking status with plasma cotinine levels. Am. J. Public Health 1979, 69, 1272–1274. [CrossRef] [PubMed]
43. Wagenknecht, L.E.; Burke, G.L.; Perkins, L.L.; Haley, N.J.; Friedman, G.D. Misclassification of smoking status in the CARDIA study: A comparison of self-report with serum cotinine levels. Am. J. Public Health 1992, 82, 33–36. [CrossRef] [PubMed]
44. Pirkle, J.L.; Flegal, K.M.; Bernert, J.T.; Brody, D.J.; Etzel, R.A.; Maurer, K.R. Exposure of the U.S. population to environmental tobacco smoke: The Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA 1996, 275, 1233–1240. [CrossRef] [PubMed]
45. Nafstad, P.; Kongerud, J.; Botten, G.; Urdal, P.; Silsand, T.; Pedersen, B.S.; Jaakkola, J.J. Fetal exposure to tobacco smoke products: A comparison between self-reported maternal smoking and concentrations of cotinine and thiocyanate in cord serum. Acta Obstet. Gynecol. Scand. 1996, 75, 902–907. [CrossRef] [PubMed]
46. Heller, W.D.; Scherer, G.; Sennewald, E.; Adlkofer, F. Misclassification of smoking in a follow-up population study in southern Germany. J. Clin. Epidemiol. 1998, 51, 211–218. [CrossRef]
47. Pichini, S.; Basagana, X.B.; Pacifici, R.; Garcia, O.; Puig, C.; Vall, O.; Harris, J.; Zuccaro, P.; Segura, J.; Sunyer, J. Cord serum cotinine as a biomarker of fetal exposure to cigarette smoke at the end of pregnancy. Environ. Health Perspect. 2000, 108, 1079–1083. [CrossRef] [PubMed]
48. Caraballo, R.S.; Giovino, G.A.; Pechacek, T.F.; Mowery, P.D. Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older: Third National Health and Nutrition Examination Survey, 1988–1994. Am. J. Epidemiol. 2001, 153, 807–814. [CrossRef] [PubMed]
49. Assaf, A.R.; Parker, D.; Lapane, K.L.; McKenney, L., Jr.; Carleton, R.A. Are there gender differences in self-reported smoking practices? Correlation with thiocyanate and cotinine levels in smokers and nonsmokers from the Pawtucket Heart Health Program. J. Women’s Health 2002, 11, 899–906. [CrossRef]
50. Seccareccia, F.; Zuccaro, P.; Pacifici, R.; Meli, P.; Pannozzo, F.; Freeman, K.M.; Santaquilani, A.; Giampaoli, S. Serum cotinine as a marker of environmental tobacco smoke exposure in epidemiological studies: The experience of the MATISS project. Eur. J. Epidemiol. 2003, 18, 487–492. [CrossRef] [PubMed]
51. Caraballo, R.S.; Giovino, G.A.; Pechacek, T.F. Self-reported cigarette smoking vs. serum cotinine among U.S. adolescents. Nicotine Tob. Res. 2004, 6, 19–25. [CrossRef] [PubMed]
52. Jeemon, P.; Agarwal, S.; Ramakrishnan, L.; Gupta, R.; Snehi, U.; Chaturvedi, V.; Reddy, K.S.; Prabhakaran, D. Validation of self-reported smoking status by measuring serum cotinine levels: An Indian perspective. Natl. Med. J. India 2010, 23, 134–136. [PubMed]
53. Riboli, E.; Preston-Martin, S.; Saracci, R.; Haley, N.J.; Trichopoulos, D.; Becher, H.; Burch, J.D.; Fontham, E.T.; Gao, Y.T.; Jindal, S.K. Exposure of nonsmoking women to environmental tobacco smoke: A 10-country collaborative study. Cancer Causes Control 1990, 1, 243–252. [CrossRef] [PubMed]
54. Pickett, K.E.; Rathouz, P.J.; Kasza, K.; Wakschlag, L.S.; Wright, R. Self-reported smoking, cotinine levels, and patterns of smoking in pregnancy. Paediatr. Perinat. Epidemiol. 2005, 19, 368–376. [CrossRef] [PubMed]
55. Zielinska-Danch, W.; Wardas, W.; Sobczak, A.; Szoltysek-Boldys, I. Estimation of urinary cotinine cut-off points distinguishing non-smokers, passive and active smokers. Biomarkers 2007, 12, 484–496. [CrossRef] [PubMed]
56. Kim, S.; Jung, A. Optimum cutoff value of urinary cotinine distinguishing South Korean adult smokers from nonsmokers using data from the KNHANES (2008–2010). Nicotine Tob. Res. 2013, 15, 1608–1616. [CrossRef] [PubMed]
57. Frendrich, M.; Mackesy-Amiti, M.E.; Johnson, T.P.; Hubbell, A.; Wislar, J.S. Tobacco-reporting validity in an epidemiological drug-use survey. Addict. Behav. 2005, 30, 175–181. [CrossRef] [PubMed]
58. Perez-Stable, E.J.; Marin, B.V.; Marin, G.; Brody, D.J.; Benowitz, N.L. Apparent underreporting of cigarette consumption among Mexican American smokers. Am. J. Public Health 1990, 80, 1057–1061. [CrossRef] [PubMed]
59. Rebagliato, M.; Bolumar, F.; Florey, C.V.; Jarvis, M.J.; Perez-Hoyos, S.; Hernandez-Aguado, I.; Avino, M.J. Variations in cotinine levels in smokers during and after pregnancy. Am. J. Obstet. Gynecol. 1998, 178, 568–571. [CrossRef]
60. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER Package; World Health Organization: Geneva, Switzerland, 2008.
61. Stoner, W.I.; Foley, B.X. Current tobacco control policy trends in the United States. Clin. Occup. Environ. Med. 2006, 5, 85–99. [PubMed]
62. Protano, C.; Vitali, M. The new danger of thirdhand smoke: Why passive smoking does not stop at secondhand smoke. Environ. Health Perspect. 2011, 119, A422. [CrossRef] [PubMed]